Interleukin-10 and its role in clinical immunoparalysis following pediatric cardiac surgery

被引:82
作者
Allen, Meredith L. [1 ]
Hoschtitzky, J. Andreas
Peters, Mark J.
Elliott, Martin
Goldman, Allan
James, Ian
Klein, Nigel J.
机构
[1] UCL, Inst Child Hlth, Crit Care Grp, Portex Unit, London, England
[2] UCL, Inst Child Hlth, Infect Dis & Microbiol Unit, London, England
[3] Great Ormond St Hosp Sick Children, London WC1N 3JH, England
关键词
cardiac surgery; immunoparalysis; interieukin-10; sepsis; genetics; outcome;
D O I
10.1097/01.CCM.0000240243.28129.36
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective. A systemic insult is associated with subsequent hyporesponsiveness to endotoxin (as measured by ex vivo tumor necrosis factor [TNF]-alpha production) and an increased risk of late nosocomial infection in some patients. When combined with low monocyte surface major histocompatibility complex class II expression, this state of altered host defense is now commonly referred to as immunoparalysis. This study was undertaken to delineate the relationship between observed levels of the antiinflammatory cytokine interleukin-10, common genetic polymorphisms that influence these levels, and the occurrence and severity of endotoxin hyporesponsiveness in children following elective cardiac surgery requiring cardiopulmonary bypass. Design: A prospective observational clinical study. Setting. A tertiary pediatric cardiac center. Patients. Thirty-six infants and children <2 yrs of age undergoing elective cardiac surgery requiring cardiopulmonary bypass. Interventions. None. Measurements and main results., We investigated the production of TNF-alpha, interleukin-6, interleukin-8, interleukin-1 receptor antagonist, and interleukin-10 in whole blood in response to lipopolysaccharide (Neisseria meningitides 10 ng/mL) in samples drawn before, during, and up to 48 hrs after surgery. Patients were genotyped for the -1082, -819, and -592 intedeukin-10 promoter polymorphisms. Whole blood cytokine response to lipopolysaccharide was reduced postoperatively to <= 50% of preoperative levels for all cytokines measured. Stimulated cytokine production was lowest in cases with the highest postoperative plasma interleukin-10 levels, which were in turn associated with the GCC haplotype. Those patients in whom the whole blood response to endotoxin was maintained (TNF-alpha >100 pg/mL) over the first 48 hrs were more likely to have an uncomplicated short stay (odds ratio 4.7, 95% confidence interval 1-22). Conclusions. Immediately following cardiac surgery, many children become relatively refractory to lipopolysaccharide stimulation. This immunoparalysis appears to be related in part to high circulating levels of interleukin-10 and places these patients at increased risk of postoperative complications. Interleukin-10 genotype may be a risk factor for immunoparalysis.
引用
收藏
页码:2658 / 2665
页数:8
相关论文
共 56 条
  • [1] Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients
    Alberti, C
    Brun-Buisson, C
    Goodman, SV
    Guidici, D
    Granton, J
    Moreno, R
    Smithies, M
    Thomas, O
    Artigas, A
    Le Gall, JR
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (01) : 77 - 84
  • [2] Early postoperative monocyte deactivation predicts systemic inflammation and prolonged stay in pediatric cardiac intensive care
    Allen, ML
    Peters, MJ
    Goldman, A
    Elliott, M
    James, I
    Callard, R
    Klein, NJ
    [J]. CRITICAL CARE MEDICINE, 2002, 30 (05) : 1140 - 1145
  • [3] Clinical review: Immunodepression in the surgical patient and increased susceptibility to infection
    Angele M.K.
    Faist E.
    [J]. Critical Care, 6 (4): : 298 - 305
  • [4] AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    ABRAMS, JH
    BERNARD, GR
    BIONDI, JW
    CALVIN, JE
    DEMLING, R
    FAHEY, PJ
    FISHER, CJ
    FRANKLIN, C
    GORELICK, KJ
    KELLEY, MA
    MAKI, DG
    MARSHALL, JC
    MERRILL, WW
    PRIBBLE, JP
    RACKOW, EC
    RODELL, TC
    SHEAGREN, JN
    SILVER, M
    SPRUNG, CL
    STRAUBE, RC
    TOBIN, MJ
    TRENHOLME, GM
    WAGNER, DP
    WEBB, CD
    WHERRY, JC
    WIEDEMANN, HP
    WORTEL, CH
    [J]. CRITICAL CARE MEDICINE, 1992, 20 (06) : 864 - 874
  • [5] The effect of methylprednisolone treatment on the cardiopulmonary bypass-induced systemic inflammatory response
    Bourbon, A
    Vionnet, M
    Leprince, P
    Vaissier, E
    Copeland, J
    McDonagh, P
    Debré, P
    Gandjbakhch, I
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2004, 26 (05) : 932 - 938
  • [6] Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: Identification of interleukin-10 as a major functional deactivator of human monocytes
    Brandtzaeg, P
    Osnes, L
    Ovstebo, R
    Joo, GB
    Westvik, AB
    Kierulf, P
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (01) : 51 - 60
  • [7] Plasma cytokines do not reflect expression of pro- and anti-inflammatory cytokine mRNA at organ level after cardiopulmonary bypass in neonatal pigs
    Brix-Christensen, V
    Vestergaard, C
    Chew, M
    Johnsen, CK
    Andersen, SK
    Dreyer, K
    Hjortdal, VE
    Ravn, HB
    Tonnesen, E
    [J]. ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2003, 47 (05) : 525 - 531
  • [8] Risk factors for long intensive care unit stay after cardiopulmonary bypass in children
    Brown, KL
    Ridout, DA
    Goldman, AP
    Hoskote, A
    Penny, DJ
    [J]. CRITICAL CARE MEDICINE, 2003, 31 (01) : 28 - 33
  • [9] CIRCULATING ENDOTOXIN AND TUMOR-NECROSIS-FACTOR DURING PEDIATRIC CARDIAC-SURGERY
    CASEY, WF
    HAUSER, GJ
    HANNALLAH, RS
    MIDGLEY, FM
    KHAN, WN
    [J]. CRITICAL CARE MEDICINE, 1992, 20 (08) : 1090 - 1096
  • [10] Methylprednisolone prevents inflammatory reaction occurring during cardiopulmonary bypass:: effects on TNF-α, IL-6, IL-8, IL-10
    Celik, JB
    Gormus, N
    Okesli, S
    Gormus, ZI
    Solak, H
    [J]. PERFUSION-UK, 2004, 19 (03): : 185 - 191